The appointed probity adviser has performed the same role for virtually every PBS policy process since 2015, including the negotiation of the past two pharmacy agreements, the $6.6 billion reform package in 2015, the government's current agreements with MA and the GBMA, and the HTA review.
Health department confirms the appointment of probity adviser for 8CPA negotiation
October 5, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Patients and clinicians defend MS treatment choice during review stakeholder meeting
November 5, 2026 - - Latest News -
Vaccines dominate public health spending but prevention investment slips
November 5, 2026 - - Latest News -
Increased accountability can be the only response to expanding authority
November 5, 2026 - - Latest News -
Sydney summit program focused on the reshaping power of AI
November 4, 2026 - - Latest News -
Is the reluctance to revisit term limits because they are such an obvious change?
November 4, 2026 - - Latest News -
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News
